Dual combination therapy versus long-acting bronchodilators alone for chronic obstructive pulmonary disease (COPD): a systematic review and network meta-analysis

Overview of attention for article published in Cochrane database of systematic reviews, December 2018

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (97th percentile)
High Attention Score compared to outputs of the same age and source (91st percentile)

So far, Altmetric has seen 8 public wall posts from 5 users.

Какие ингаляционные средства длительного действия наиболее эффективны и безопасны для людей с поздними стадиями хронической обстр…

Dual combination therapy versus long‐acting bronchodilators alone for chronic obstructive pulmonary disease (COPD): a…

The LABA/LAMA combination is likely the best treatment in preventing COPD flare‐ups, reports a Cochrane systematic review. It…

New Cochrane Airways evidence from a network meta-analysis on long-acting inhalers for people with COPD https://buff.ly/2EdE9le

New evidence from a network meta-analysis on long-acting inhalers for people with #COPD http://bit.ly/2KZMt8Z Cochrane UK #Cochra…

ICS‐containing inhalers are associated with an increased risk of pneumonia ow.ly/lqYC30mQDbr [4/4]

So how big was this review? Well it had 99 studies and 101,000 people. It incorporated a network meta-analysis which can rank a…

Here it is in all it's glory! #CochraneEvidence: Dual combination therapy versus long‐acting bronchodilators alone for chronic…